In vitro and in vivo evidences propound therapeutic potential of Lipocalin 2 in cervical carcinoma
N. Dwivedi, T. Mazumder, G. Veeraraghavan, R. Siva, S. P K, R. Ranade, M. Das, S. K. Dhar
This study shows that inhibiting LCN2 with a monoclonal antibody reduces cervical cancer cell proliferation, invasion, and tumor growth in vitro and in vivo.
bioRxiv · Jan 13, 2023 · PreprintCancer Biology